Sponsor:
Fate Therapeutics
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Fate Therapeutics on 2024-12-24.